Consensus RadNet, Inc.

Stocks

RDNT

US7504911022

Healthcare Facilities & Services

Market Closed - Nasdaq 16:00:00 2026-10-13 EDT			5-day change	1st Jan Change
71.51 ^USD	+0.03%		+1.75%	+0.22%

10-01	RadNet, WIN-NextGen Collaborating on Medical Imaging Career Initiative	MT
09-16	RadNet, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 07:45 AM

Evolution of the Average Target: RadNet, Inc.

Evolution of the Target Price: RadNet, Inc.

Changes in Analyst Recommendations: RadNet, Inc.

c4908b0af26f407854f29974c51632dd.f9S57OMLmEtRbBwEGFba2C4dXfhIPrKd1yiS7HAd-FQ.KKCLgIdq138yWFNmQgCToH8oObUnTdiq5EX7rjZLsTMIg8-E00jtfDUFXQ~34b7b9b8aa9b2ed0f63f0002bbd30bf3

Analysts' recommendations: RadNet, Inc.

08-11	B. Riley Adjusts Price Target on RadNet to $96 From $83, Maintains Buy Rating	MT
08-11	Truist Adjusts Price Target on RadNet to $94 From $90, Maintains Buy Rating	MT
05-01	B. Riley Adjusts Price Target on RadNet to $83 From $87, Maintains Buy Rating	MT
12-01	B. Riley Raises Price Target on RadNet to $87 From $71, Keeps Buy Rating	MT
11-12	Truist Raises Price Target on RadNet to $90 From $81, Keeps Buy Rating	MT
25-09-03	Truist Raises Price Target on RadNet to $81 From $74, Keeps Buy Rating	MT
25-08-12	B. Riley Adjusts Price Target on RadNet to $71 From $69, Maintains Buy Rating	MT
25-06-13	B. Riley Initiates RadNet at Buy With $69 Price Target	MT
25-04-17	RadNet's iCAD Deal to Expand its Digital Health Services and Geographic Presence, Truist Says	MT
25-04-11	Truist Securities Cuts Price Target on RadNet to $74 From $88, Keeps Buy Rating	MT
25-01-22	Truist Securities Cuts Price Target on RadNet to $88 From $94, Keeps Buy Rating	MT
24-11-29	Truist Raises Price Target on RadNet to $94 From $80, Keeps Buy Rating	MT
24-11-11	Top Midday Gainers	MT
24-10-04	Sidoti Adjusts RadNet Price Target to $88 From $72, Maintains Buy Rating	MT
24-09-23	Truist Raises Price Target on RadNet to $80 From $70, Maintains Buy Rating	MT
24-09-06	Barclays Upgrades RadNet to Overweight From Equal Weight	MT
24-07-15	Truist Securities Adjusts Price Target on RadNet to $70 From $63, Maintains Buy Rating	MT
24-07-11	Jefferies Adjusts Price Target on RadNet to $75 From $61, Maintains Buy Rating	MT
24-05-15	Truist Securities Adjusts Price Target on RadNet to $63 From $55, Maintains Buy Rating	MT
24-03-28	Truist Securities Raises Price Target on RadNet to $55 From $51, Maintains Buy Rating	MT
24-03-06	Barclays Starts Coverage on RadNet With Equalweight Rating, $48 Price Target	MT
24-03-04	Truist Securities Adjusts RadNet Price Target to $51 From $42, Maintains Buy Rating	MT
23-12-08	Truist Adjusts RadNet's Price Target to $42 From $40, Maintains Buy Rating	MT
23-08-31	Truist Securities Starts RadNet at Buy With $40 Price Target	MT
23-06-26	Raymond James Raises Price Target on RadNet to $40 From $35, Keeps Outperform Rating	MT

More recommendations

Medical & Diagnostic Laboratories

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	RADNET, INC.					+32.32%
	CVS HEALTH CORPORATION					+31.9%
	HCA HEALTHCARE, INC.					-0.03%
	NATERA, INC.					+0.93%
	FRESENIUS SE & CO. KGAA					+29.87%
	QUEST DIAGNOSTICS INCORPORATED					+7.96%
	LABCORP HOLDINGS INC.					+10.04%
	TENET HEALTHCARE CORPORATION					+6.9%
	DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY					+17.7%
	REDE D'OR SÃO LUIZ S.A.					+9.67%
	Average					+14.73%
	Weighted average by Cap.					+13.95%